Kevand
Established Member
- Reaction score
- 46
Bicalutamide reduces the size of the prostate gland and seminal vesicles,[171] though not of the testes.[172] Significantly reduced penile length is also a recognized adverse effect of ADT.[115][173] Reversible hypospermia or aspermia (that is, reduced or absent semen/ejaculate production) may occur.[174]
I would like a bigger dick dude not a smaller one
Those are recognized adverse effect of ADT. ADT usually includes chemical or surgical castration with anti-androgen. That's a heavy heavy therapy which nulify androgen signaling and testosterone levels. I think this adverse effect can't be extrapolerized to bicalutamide as a monotherapy. Bicalutamide as a monotherapy increase the testosterone level up to 2-fold which is problem in feminiziation and prostate cancer therapies, and should help in maintain sexual function. Studies, reviews and anedocts with bicalutamide as a monotherapy reports relatively few side sexual side effects which is even less with topical use.
Edit: I read the references and to be clear in their review ADT was a combined castration treatment. So the wikipedia information can be somewhat misleading.